Fusion Micro Finance Limited
FUSION.NS News Today: Stay Updated with the Latest Fusion Micro Finance Limited News in Real Time
Find FUSION.NS news now at Meyka AI. Stay informed with the latest Fusion Micro Finance Limited stocks updates, including price news, market analysis, and expert insights.
0396.HK Stock Surges 51.8% on High Volume Trading in Hong Kong
0396.HK stock jumps 51.78% with 5.68M shares traded. Hing Lee Holdings shows strong momentum on HKSE today.
SBFM Director Natan David Acquires 100K Shares – April 15, 2026
Sunshine Biopharma director Natan David acquired 100,000 common stock shares on April 14, 2026. Insider buying signal for SBFM stock.
V8Y.SI Stock Surges 100% on High Volume Trading in Singapore
V8Y.SI stock price doubled to S$0.002 on 1.15M volume. Quantum Healthcare Limited shows extreme volatility on SES exchange.
MJRX.CN Stock Plunges 25% on Apr 15 as Global Health Clinics Faces Headwinds
MJRX.CN stock fell 25% to C$0.03 on Apr 15, 2026. Global Health Clinics Ltd. faces severe financial challenges with negative margins.
UTINIFTETF.BO Holds Steady at 288.77 INR on BSE, April 15
UTI Nifty ETF (UTINIFTETF.BO) trades flat at 288.77 INR on BSE. Market cap 622B. Meyka AI rates it B grade with HOLD suggestion.
IDYA Maintained at Outperform by Wedbush April 2026
Wedbush maintained IDYA at Outperform, raising price target to $58 from $52 on April 14, 2026.
Alibaba Group Shares Rise on Cloud and Cybersecurity Price Hikes
Alibaba shares rose after the company increased prices across its cloud computing and cybersecurity services, signaling stronger monetization of its fast-growing AI-driven cloud business. The move reflects rising global demand for artificial intelligence infrastructure and higher operating costs in advanced data centers. Investors reacted positively because the decision shows Alibaba is gaining pricing power at…
ALSTONE.BO Stock Flat at ₹0.13 on BSE, 165M Shares Traded Apr 15
ALSTONE.BO stock closed flat at ₹0.13 on BSE with 165.8M shares traded. Meyka AI rates it Grade B with HOLD suggestion.
SNAL Outperform Rating Maintained by Noble Capital, April 2026
Noble Capital Markets maintains Outperform rating on SNAL, raises price target to $3.50 from $2.75.